SK Biopharmaceuticals Co., Ltd. (KRX:326030)
102,600
+200 (0.20%)
Apr 28, 2026, 3:30 PM KST
-0.58% (1Y)
| Market Cap | 8.03T |
| Revenue (ttm) | 706.74B |
| Net Income (ttm) | 266.95B |
| Shares Out | 78.31M |
| EPS (ttm) | 3,408.75 |
| PE Ratio | 30.10 |
| Forward PE | 30.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 171,337 |
| Average Volume | 169,774 |
| Open | 101,900 |
| Previous Close | 102,400 |
| Day's Range | 101,100 - 102,600 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.86 |
| RSI | 52.38 |
| Earnings Date | May 11, 2026 |